{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:11:01Z","timestamp":1793394661356,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2022C7ZR3W"],"award-info":[{"award-number":["2022C7ZR3W"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2022C7ZR3W"],"award-info":[{"award-number":["2022C7ZR3W"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18172-x","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T11:16:14Z","timestamp":1756811774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A potential age-independent MASLD-related liver fibrosis index based on metabolic profiling"],"prefix":"10.1038","volume":"15","author":[{"given":"Serena","family":"Zampieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Petrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Nagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Micheli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Maiorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilena","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Sabetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Miglionico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marin","family":"Pecani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Raparelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Basili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Stefanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Oscar","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Precision Medicine Liver Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Pelliccelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Andreozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Cacciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2","family":"Sperduti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Recchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Rumbola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cangemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Miele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Stronati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moris","family":"Sangineto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Serviddio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Desantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Pizzichetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio Francesco","family":"Romiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"18172_CR1","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol. 79, 1542\u20131556 (2023).","journal-title":"J. Hepatol."},{"key":"18172_CR2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/biomedicines11030883","volume":"11","author":"A Boccatonda","year":"2023","unstructured":"Boccatonda, A. et al. From NAFLD to MAFLD: Definition pathophysiological basis and cardiovascular implications. Biomedicines 11, 883 (2023).","journal-title":"Biomedicines"},{"key":"18172_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.biopha.2012.10.002","volume":"67","author":"D Kong","year":"2013","unstructured":"Kong, D., Zhang, F., Zhang, Z., Lu, Y. & Zheng, S. Clearance of activated stellate cells for hepatic fibrosis regression: Molecular basis and translational potential. Biomed. Pharmacother. 67, 246\u2013250 (2013).","journal-title":"Biomed. Pharmacother."},{"key":"18172_CR4","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","volume":"383","author":"EA Tsochatzis","year":"2014","unstructured":"Tsochatzis, E. A., Bosch, J. & Burroughs, A. K. Liver cirrhosis. The Lancet 383, 1749\u20131761 (2014).","journal-title":"The Lancet"},{"key":"18172_CR5","doi-asserted-by":"publisher","first-page":"032","DOI":"10.29328\/journal.ascr.1001081","volume":"8","author":"P Elena","year":"2024","unstructured":"Elena, P., Raluca Ioana, A., Andrei Emilian, P. & Adorata Elena, C. Non-invasive serological markers of hepatic fibrosis\u2014mini review. Arch. Surge. Clin. Res. 8, 032\u2013038 (2024).","journal-title":"Arch. Surge. Clin. Res."},{"key":"18172_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/transplantology4020008","volume":"4","author":"P Auricchio","year":"2023","unstructured":"Auricchio, P. & Finotti, M. From NAFLD to chronic liver diseases. assessment of liver fibrosis through non-invasive methods before liver transplantation: Can we rely on them?. Transplantology 4, 71\u201384 (2023).","journal-title":"Transplantology"},{"key":"18172_CR7","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3390\/biomedicines9111617","volume":"9","author":"R Zupo","year":"2021","unstructured":"Zupo, R. et al. Liver fibrosis and 8-year all-cause mortality trajectories in the aging cohort of the Salus in Apulia study. Biomedicines 9, 1617 (2021).","journal-title":"Biomedicines"},{"key":"18172_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-020-01240-z","volume":"20","author":"P Pitisuttithum","year":"2020","unstructured":"Pitisuttithum, P. et al. Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: The GOASIA study. BMC Gastroenterol 20, 1\u20139 (2020).","journal-title":"BMC Gastroenterol"},{"key":"18172_CR9","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.jhep.2008.08.011","volume":"49","author":"P Nahon","year":"2008","unstructured":"Nahon, P. et al. Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease. J. Hepatol. 49, 1062\u20131068 (2008).","journal-title":"J. Hepatol."},{"key":"18172_CR10","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.gastha.2022.07.012","volume":"1","author":"K Kariyama","year":"2022","unstructured":"Kariyama, K. et al. Fibrosis-3 index: a new score to predict liver fibrosis in patients with nonalcoholic fatty liver disease without age as a factor. Gastro. Hep. Adv. 1, 1108\u20131113 (2022).","journal-title":"Gastro. Hep. Adv."},{"key":"18172_CR11","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1016\/j.jceh.2016.06.170","volume":"6","author":"N Krishnasamy","year":"2016","unstructured":"Krishnasamy, N. et al. Non-invasive markers: Fibrometer, fibroscan vs liver biopsy in detecting liver fibrosis in HBV patients. J. Clin. Exp. Hepatol. 6, S100\u2013S101 (2016).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"18172_CR12","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1111\/jgh.14156","volume":"33","author":"Y Ogawa","year":"2018","unstructured":"Ogawa, Y. et al. Wisteria floribunda agglutinin-positive Mac-2-binding protein and type 4 collagen 7S: Useful markers for the diagnosis of significant fibrosis in patients with non-alcoholic fatty liver disease. J. Gastroenterol Hepatol. 33, 1795\u20131803 (2018).","journal-title":"J. Gastroenterol Hepatol."},{"key":"18172_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-56796-7","volume":"14","author":"EK Choe","year":"2024","unstructured":"Choe, E. K. & Kang, H. Y. The association between platelet-related parameters and nonalcoholic fatty liver disease in a metabolically healthy nonobese population. Sci. Rep. 14, 1\u20138 (2024).","journal-title":"Sci. Rep."},{"key":"18172_CR14","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.27332","volume":"61","author":"E Seki","year":"2015","unstructured":"Seki, E. & Schwabe, R. F. Hepatic inflammation and fibrosis: Functional links and key pathways. Hepatology 61, 1066\u20131079 (2015).","journal-title":"Hepatology"},{"key":"18172_CR15","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3390\/antiox12081604","volume":"12","author":"DS Semenovich","year":"2023","unstructured":"Semenovich, D. S. et al. Fibrosis development linked to alterations in glucose and energy metabolism and prooxidant-antioxidant balance in experimental models of liver injury. Antioxidants 12, 1604 (2023).","journal-title":"Antioxidants"},{"key":"18172_CR16","doi-asserted-by":"publisher","first-page":"1231003","DOI":"10.1142\/S0219720012310038","volume":"10","author":"W Li","year":"2012","unstructured":"Li, W. Volcano plots in analyzing differential expressions with mRNA microarrays. J. Bioinform. Comput. Biol. 10, 1231003 (2012).","journal-title":"J. Bioinform. Comput. Biol."},{"key":"18172_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/926169","volume":"2015","author":"H Enomoto","year":"2015","unstructured":"Enomoto, H. et al. A new metabolism-related index correlates with the degree of liver fibrosis in hepatitis C virus-positive patients. Gastroenterol. Res. Pract. 2015, 926169 (2015).","journal-title":"Gastroenterol. Res. Pract."},{"key":"18172_CR18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S1665-2681(19)31011-7","volume":"12","author":"H Enomoto","year":"2013","unstructured":"Enomoto, H. et al. Association of amino acid imbalance with the severity of liver fibrosis and esophageal varices. Ann. Hepatol. 12, 471\u2013478 (2013).","journal-title":"Ann. Hepatol."},{"key":"18172_CR19","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.3748\/wjg.v18.i17.2005","volume":"18","author":"T Ishikawa","year":"2012","unstructured":"Ishikawa, T. Branched-chain amino acids to tyrosine ratio value as a potential prognostic factor for hepatocellular carcinoma. World J. Gastroenterol. 18, 2005\u20132008 (2012).","journal-title":"World J. Gastroenterol."},{"key":"18172_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1872-034X.2009.00614.x","volume":"40","author":"K Michitaka","year":"2010","unstructured":"Michitaka, K. et al. Amino acid imbalance in patients with chronic liver diseases. Hepatol. Res. 40, 393\u2013398 (2010).","journal-title":"Hepatol. Res."},{"key":"18172_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-024-03129-7","volume":"24","author":"M Thing","year":"2024","unstructured":"Thing, M. et al. Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver disease. BMC Gastroenterol. 24, 1\u201310 (2024).","journal-title":"BMC Gastroenterol."},{"key":"18172_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcmgh.2019.12.006","volume":"10","author":"K Du","year":"2020","unstructured":"Du, K. et al. Increased glutaminolysis marks active scarring in nonalcoholic steatohepatitis progression. Cell. Mol. Gastroenterol. Hepatol. 10, 1\u201321 (2020).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"18172_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000845","author":"RK Sterling","year":"2024","unstructured":"Sterling, R. K. et al. AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology https:\/\/doi.org\/10.1097\/HEP.0000000000000845 (2024).","journal-title":"Hepatology"},{"key":"18172_CR24","doi-asserted-by":"publisher","first-page":"bvae152","DOI":"10.1210\/jendso\/bvae152","volume":"8","author":"E Pitti","year":"2024","unstructured":"Pitti, E. et al. Metabolic crosstalk in multimorbidity: identifying compensatory effects among diabetes, hypertension, and dyslipidemia. J. Endocr. Soc 8, bvae152 (2024).","journal-title":"J. Endocr. Soc"},{"key":"18172_CR25","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.3390\/jcm10122705","volume":"10","author":"N Godbole","year":"2021","unstructured":"Godbole, N. et al. Prognostic and pathophysiologic significance of il-8 (Cxcl8) in biliary atresia. J. Clin. Med. 10, 2705 (2021).","journal-title":"J. Clin. Med."},{"key":"18172_CR26","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/hep4.1237","volume":"2","author":"O Glass","year":"2018","unstructured":"Glass, O. et al. Serum interleukin-8, osteopontin, and monocyte chemoattractant protein 1 are associated with hepatic fibrosis in patients with nonalcoholic fatty liver disease. Hepatol. Commun. 2, 1344\u20131355 (2018).","journal-title":"Hepatol. Commun."},{"key":"18172_CR27","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi, C., Garagnani, P., Parini, P., Giuliani, C. & Santoro, A. Inflammaging: A new immune-metabolic viewpoint for age-related diseases. Nat. Rev. Endocrinol. 14, 576\u2013590 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"18172_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4103\/ijd.ijd_1015_22","volume":"68","author":"V Yadav","year":"2023","unstructured":"Yadav, V. et al. Interleukin levels and non-alcoholic fatty liver disease in chronic plaque psoriasis: An analytical case control study. Indian J. Dermatol. 68, 377\u2013384 (2023).","journal-title":"Indian J. Dermatol."},{"key":"18172_CR29","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1002\/hep.32776","volume":"77","author":"J Knorr","year":"2023","unstructured":"Knorr, J. et al. Interleukin-18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis. Hepatology 77, 1968\u20131982 (2023).","journal-title":"Hepatology"},{"key":"18172_CR30","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3748\/wjg.v24.i12.1312","volume":"24","author":"YQ Wang","year":"2018","unstructured":"Wang, Y. Q., Cao, W. J., Gao, Y. F., Ye, J. & Zou, G. Z. Serum interleukin-34 level can be an indicator of liver fibrosis in patients with chronic hepatitis B virus infection. World J. Gastroenterol. 24, 1312\u20131320 (2018).","journal-title":"World J. Gastroenterol."},{"key":"18172_CR31","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.3390\/ijms24043487","volume":"24","author":"H Aslam","year":"2023","unstructured":"Aslam, H. et al. The role of red cell distribution width as a prognostic marker in chronic liver disease: A literature review. Int. J. Mole. Sci. 24, 3487 (2023).","journal-title":"Int. J. Mole. Sci."},{"key":"18172_CR32","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/MEG.0b013e328365c403","volume":"26","author":"W Yang","year":"2014","unstructured":"Yang, W., Huang, H., Wang, Y., Yu, X. & Yang, Z. High red blood cell distribution width is closely associated with nonalcoholic fatty liver disease. Eur. J. Gastroenterol. Hepatol. 26, 174\u2013178 (2014).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"18172_CR33","doi-asserted-by":"publisher","first-page":"7412","DOI":"10.3748\/wjg.v19.i42.7412","volume":"19","author":"M Cengiz","year":"2013","unstructured":"Cengiz, M., Candir, B. A., Yilmaz, G., Akyol, G. & Ozenirler, S. Is increased red cell distribution width an indicating marker of nonalcoholic steatohepatitis and fibrotic stage?. World J. Gastroenterol. 19, 7412\u20137418 (2013).","journal-title":"World J. Gastroenterol."},{"key":"18172_CR34","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3350\/cmh.2013.19.3.258","volume":"19","author":"HM Kim","year":"2013","unstructured":"Kim, H. M. et al. Elevated red cell distribution width is associated with advanced fibrosis in NAFLD. Clin. Mol. Hepatol. 19, 258\u2013265 (2013).","journal-title":"Clin. Mol. Hepatol."},{"key":"18172_CR35","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.61116","author":"M Sun","year":"2024","unstructured":"Sun, M. et al. Serum creatinine as an independent predictor of moderate to severe fibrosis in chinese american non-obese metabolic dysfunction-associated steatotic liver disease. Cureus https:\/\/doi.org\/10.7759\/cureus.61116 (2024).","journal-title":"Cureus"},{"key":"18172_CR36","first-page":"1213","volume":"10","author":"R Kumar","year":"2022","unstructured":"Kumar, R., Prakash, S. S., Priyadarshi, R. N. & Anand, U. Sarcopenia in chronic liver disease: A metabolic perspective. J. Clin. Trans. Hepatol. 10, 1213\u20131222 (2022).","journal-title":"J. Clin. Trans. Hepatol."},{"key":"18172_CR37","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1017\/S0007114523000399","volume":"130","author":"T Zhou","year":"2023","unstructured":"Zhou, T. et al. Impact of skeletal muscle mass evaluating methods on severity of metabolic associated fatty liver disease in non-elderly adults. Br. J. Nutr. 130, 1373\u20131384 (2023).","journal-title":"Br. J. Nutr."},{"key":"18172_CR38","doi-asserted-by":"publisher","first-page":"356","DOI":"10.14218\/JCTH.2021.00247","volume":"10","author":"\u00c1 Rojas","year":"2022","unstructured":"Rojas, \u00c1., Garc\u00eda-Lozano, M. R., Gil-G\u00f3mez, A., Romero-G\u00f3mez, M. & Ampuero, J. Glutaminolysis-ammonia-urea cycle axis, non-alcoholic fatty liver disease progression and development of novel therapies. J. Clin. Trans. Hepatol. 10, 356\u2013362 (2022).","journal-title":"J. Clin. Trans. Hepatol."},{"key":"18172_CR39","doi-asserted-by":"publisher","first-page":"383762","DOI":"10.3389\/fendo.2018.00455","volume":"9","author":"EH Cho","year":"2018","unstructured":"Cho, E. H. Succinate as a regulator of hepatic stellate cells in liver fibrosis. Front Endocrinol. (Lausanne) 9, 383762 (2018).","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"18172_CR40","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00535-019-01649-8","volume":"55","author":"H Hu","year":"2019","unstructured":"Hu, H. et al. Intestinal microbiome and NAFLD: Molecular insights and therapeutic perspectives. J. Gastroenterol. 55, 142\u2013158 (2019).","journal-title":"J. Gastroenterol."},{"key":"18172_CR41","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s00125-024-06196-3","volume":"67","author":"E Summary","year":"2024","unstructured":"Summary, E. EASL\u2013EASD\u2013EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Diabetologia 67, 2375\u20132392 (2024).","journal-title":"Diabetologia"},{"key":"18172_CR42","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jhep.2010.05.035","volume":"53","author":"F Degos","year":"2010","unstructured":"Degos, F. et al. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study). J. Hepatol. 53, 1013\u20131021 (2010).","journal-title":"J. Hepatol."},{"key":"18172_CR43","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.3390\/app9091961","volume":"9","author":"CJ Chen","year":"2019","unstructured":"Chen, C. J. et al. Effects of hepatic steatosis on non-invasive liver fibrosis measurements between hepatitis b and other etiologies. Appl. Sci. 9, 1961 (2019).","journal-title":"Appl. Sci."},{"key":"18172_CR44","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"F Tacke","year":"2024","unstructured":"Tacke, F. et al. EASL\u2013EASD\u2013EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J. Hepatol. 81, 492\u2013542 (2024).","journal-title":"J. Hepatol."},{"key":"18172_CR45","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78, 1966\u20131986 (2023).","journal-title":"Hepatology"},{"key":"18172_CR46","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes, P. J. et al. Accuracy of fibroscan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 156, 1717\u20131730 (2019).","journal-title":"Gastroenterology"},{"key":"18172_CR47","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling, R. K. et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43, 1317\u20131325 (2006).","journal-title":"Hepatology"},{"key":"18172_CR48","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1021\/ac051632c","volume":"78","author":"F Dieterle","year":"2006","unstructured":"Dieterle, F., Ross, A., Schlotterbeck, G. & Senn, H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in1H NMR metabonomics. Anal. Chem. 78, 4281\u20134290 (2006).","journal-title":"Anal. Chem."},{"key":"18172_CR49","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa, P. & Poynard, T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 24, 289\u2013293 (1996).","journal-title":"Hepatology"},{"key":"18172_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2164-7-142","volume":"7","author":"RA van den Berg","year":"2006","unstructured":"van den Berg, R. A., Hoefsloot, H. C. J. J., Westerhuis, J. A., Smilde, A. K. & van der Werf, M. J. Centering, scaling, and transformations: Improving the biological information content of metabolomics data. BMC Genomics 7, 1\u201315 (2006).","journal-title":"BMC Genomics"},{"key":"18172_CR51","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/0049124104268644","volume":"33","author":"KP Burnham","year":"2004","unstructured":"Burnham, K. P. & Anderson, D. R. Multimodel inference: Understanding AIC and BIC in model selection. Sociol. Methods Res. 33, 261\u2013304 (2004).","journal-title":"Sociol. Methods Res."},{"key":"18172_CR52","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1109\/TKDE.2019.2912815","volume":"32","author":"TT Wong","year":"2020","unstructured":"Wong, T. T. & Yeh, P. Y. Reliable accuracy estimates from k-fold cross validation. IEEE Trans. Knowl. Data Eng. 32, 1586\u20131594 (2020).","journal-title":"IEEE Trans. Knowl. Data Eng."},{"key":"18172_CR53","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","volume":"21","author":"EW Steyerberg","year":"2010","unstructured":"Steyerberg, E. W. et al. Assessing the performance of prediction models: A framework for traditional and novel measures. Epidemiology 21, 128\u2013138 (2010).","journal-title":"Epidemiology"},{"key":"18172_CR54","first-page":"153","volume":"36","author":"A Buse","year":"1982","unstructured":"Buse, A. The likelihood ratio, wald, and lagrange multiplier tests: An expository note. Am. Stat. 36, 153\u2013157 (1982).","journal-title":"Am. Stat."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18172-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18172-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18172-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:42:01Z","timestamp":1757313721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18172-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18172"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18172-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32328"}}